BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23965504)

  • 1. Weight uniformity of scored tablet halves manufactured by palestinian pharmaceutical companies.
    Zaid AN; Abu GA; Kittana N
    Int J Pharm Compd; 2010; 14(3):257-60. PubMed ID: 23965504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements.
    Zaid AN; Ghosh AA
    Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
    Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M
    PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of medication dose uniformity in commonly split tablets.
    Teng J; Song CK; Williams RL; Polli JE
    J Am Pharm Assoc (Wash); 2002; 42(2):195-9. PubMed ID: 11926662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
    Helmy SA
    J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tablet Splitting of Antiepileptic Drugs in Pediatric Epilepsy: Potential Effect on Plasma Drug Concentrations.
    Nidanapu RP; Rajan S; Mahadevan S; Gitanjali B
    Paediatr Drugs; 2016 Dec; 18(6):451-463. PubMed ID: 27704404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different splitting techniques on the characteristics of divided tablets of five commonly split drug products in Jordan.
    Gharaibeh SF; Tahaineh L
    Pharm Pract (Granada); 2020; 18(2):1776. PubMed ID: 32377280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The practice and clinical implications of tablet splitting in international health.
    Elliott I; Mayxay M; Yeuichaixong S; Lee SJ; Newton PN
    Trop Med Int Health; 2014 Jul; 19(7):754-60. PubMed ID: 24702766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight uniformity of split tablets required by a Veterans Affairs policy.
    Polli JE; Kim S; Martin BR
    J Manag Care Pharm; 2003; 9(5):401-7. PubMed ID: 14613437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tablet splitting: a review of weight and content uniformity.
    Freeman MK; White W; Iranikhah M
    Consult Pharm; 2012 May; 27(5):341-52. PubMed ID: 22591978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice.
    Tahaineh LM; Gharaibeh SF
    J Pharm Pract; 2012 Aug; 25(4):471-6. PubMed ID: 22544621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets.
    Vranić E; Uzunović A
    Bosn J Basic Med Sci; 2007 Nov; 7(4):328-34. PubMed ID: 18039191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and stability evaluation of extemporaneously prepared atenolol capsules from crushed atenolol tablets.
    Zaid AN; Malkieh N; Kharoaf M; Abu Ghoush A; Al-Ramahi R
    Int J Pharm Compd; 2012; 16(4):342-6. PubMed ID: 23050394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight and content uniformity of lorazepam half-tablets: A study of correlation of a low drug content product.
    Zaid AN; Al-Ramahi RJ; Ghoush AA; Qaddumi A; Zaaror YA
    Saudi Pharm J; 2013 Jan; 21(1):71-5. PubMed ID: 23960821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets.
    Fahelelbom KM; Al-Tabakha MM; Eissa NA; Javadi J
    Sci Pharm; 2016 Oct; 84(4):646-653. PubMed ID: 27727195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raman spectroscopy for the analytical quality control of low-dose break-scored tablets.
    Gómez DA; Coello J; Maspoch S
    J Pharm Biomed Anal; 2016 May; 124():207-215. PubMed ID: 26962721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practices of tablet splitting and dose uniformity of fragments at public hospitals in Ethiopia: A cross-sectional study supported by experimental findings.
    Emagn Kasahun A; Joseph NM; Belete A
    PLoS One; 2022; 17(12):e0279135. PubMed ID: 36520879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raman spectroscopy as a complementary tool to assess the content uniformity of dosage units in break-scored warfarin tablets.
    Arruabarrena J; Coello J; Maspoch S
    Int J Pharm; 2014 Apr; 465(1-2):299-305. PubMed ID: 24508332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.